Nanotechnology and vaccine development

Nanotechnology in vaccine delivery

*Corresponding author Dr. Wahid Khan, Ph.D Assistant Professor Department of Pharmaceutics National Insititute of Pharmaceutical Education and Research Balanagar, Hyderabad 500 037, Andhra Pradesh, INDIA E-Mail: [email protected] ABSTRACT Success of vaccination in dealing with the communicable diseases can be clearly understood by eradication of smallpox and the imminent decrease of polio, a...

Nanotechnology: a Revolutionising Vaccine Delivery System

Hepatitis C Virus and Vaccine Development

The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generating new vaccines or drugs is an obligation. However, there is no vaccine available for clinical u...

Nanotechnology in Military Development

1 Ethics and the Development of Nanotechnology

1 I have little to contribute directly to ethical reflection that specifically deals with risks that might be occasioned by innovations of nanotechnology (Schummer, 2007; Shelley, 2006), and with how to promote responsible conduct and public trust in the face of them (Weil, 2006). Instead, I will introduce a general ethical stance towards technoscientific research and innovations, one that I ha...